KRAS and exocrine pancreatic carcinoma: In this work, the authors selectively amplified KRAS-mutated alleles in ccfDNA of pancreatic carcinoma patients by means of allele-specific polymerase chain reaction (PCR) and confirmed their results by Sanger sequencing.